Skip to content

Clinical trials

Phase 1 Myelodysplastic Syndromes trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1 Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20131
20143
20153
20162
20173
20184
20202
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated6
Active, not recruiting2
Recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Internationales Servier3
Novartis Pharmaceuticals3
Institut Paoli-Calmettes2
Janssen Research & Development, LLC2
AbbVie1
Agios Pharmaceuticals, Inc.1
Amgen1
Bayer1
Bioniche Pharma USA LLC1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes25
Leukemia, Myeloid, Acute20
Leukemia, Myelomonocytic, Chronic9
Leukemia4
Hematologic Neoplasms3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Non-Hodgkin2
Recurrence2
Bone Marrow Diseases1
Hematologic Diseases1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.